{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,16]],"date-time":"2026-01-16T20:20:25Z","timestamp":1768594825418,"version":"3.49.0"},"reference-count":48,"publisher":"Oxford University Press (OUP)","issue":"9","license":[{"start":{"date-parts":[[2023,6,28]],"date-time":"2023-06-28T00:00:00Z","timestamp":1687910400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"funder":[{"DOI":"10.13039\/100000050","name":"National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","award":["K01HL133468"],"award-info":[{"award-number":["K01HL133468"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","award":["R01HL130500-01A1"],"award-info":[{"award-number":["R01HL130500-01A1"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","award":["K01HL140170"],"award-info":[{"award-number":["K01HL140170"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","award":["HHSN268200900040C"],"award-info":[{"award-number":["HHSN268200900040C"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","award":["HHSN268200900046C"],"award-info":[{"award-number":["HHSN268200900046C"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","award":["HHSN268200900047C"],"award-info":[{"award-number":["HHSN268200900047C"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","award":["HHSN268200900048C"],"award-info":[{"award-number":["HHSN268200900048C"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","award":["HHSN268200900049C"],"award-info":[{"award-number":["HHSN268200900049C"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007875","name":"Tulane University","doi-asserted-by":"publisher","award":["P30GM103337"],"award-info":[{"award-number":["P30GM103337"]}],"id":[{"id":"10.13039\/100007875","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007698","name":"University of Florida","doi-asserted-by":"publisher","award":["UL1 TR000064"],"award-info":[{"award-number":["UL1 TR000064"]}],"id":[{"id":"10.13039\/100007698","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,8,5]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Background<\/jats:title>\n                  <jats:p>The Systolic Blood Pressure Intervention Trial (SPRINT) demonstrated an intensive (&amp;lt;120 mm Hg) vs. standard (&amp;lt;140 mm Hg) systolic blood pressure (SBP) goal lowered cardiovascular disease (CVD) risk. Estimating the effect of intensive SBP lowering among SPRINT-eligible adults most likely to benefit can guide implementation efforts.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>We studied SPRINT participants and SPRINT-eligible participants in the Reasons for Geographic and Racial Differences in Stroke (REGARDS) Study and National Health and Nutrition Examination Surveys (NHANES). A published algorithm of predicted CVD benefit with intensive SBP treatment was used to categorize participants into low, medium, or high predicted benefit. CVD event rates were estimated with intensive and standard treatment.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>Median age was 67.0, 72.0, and 64.0 years in SPRINT, SPRINT-eligible REGARDS, and SPRINT-eligible NHANES participants, respectively. The proportion with high predicted benefit was 33.0% in SPRINT, 39.0% in SPRINT-eligible REGARDS, and 23.5% in SPRINT-eligible NHANES. The estimated difference in CVD event rate (standard minus intensive) was 7.0 (95% confidence interval [CI] 3.4\u201310.7), 8.4 (95% CI 8.2\u20138.5), and 6.1 (95% CI 5.9\u20136.3) per 1,000 person-years in SPRINT, SPRINT-eligible REGARDS participants, and SPRINT-eligible NHANES participants, respectively (median 3.2-year follow-up). Intensive SBP treatment could prevent 84,300 (95% CI 80,800\u201387,920) CVD events per year in 14.1 million SPRINT-eligible US adults; 29,400 and 28,600 would be in 7.0 million individuals with medium or high predicted benefit, respectively.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusions<\/jats:title>\n                  <jats:p>Most of the population health benefit from intensive SBP goals could be achieved by treating those characterized by a previously published algorithm as having medium or high predicted benefit.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/ajh\/hpad047","type":"journal-article","created":{"date-parts":[[2023,6,28]],"date-time":"2023-06-28T13:35:27Z","timestamp":1687959327000},"page":"498-508","source":"Crossref","is-referenced-by-count":9,"title":["Estimated Population Health Benefits of Intensive Systolic Blood Pressure Treatment Among SPRINT-Eligible US Adults"],"prefix":"10.1093","volume":"36","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7382-4607","authenticated-orcid":false,"given":"Catherine G","family":"Derington","sequence":"first","affiliation":[{"name":"Intermountain Healthcare Department of Population Health Sciences, Spencer Fox Eccles School of Medicine, University of Utah , Salt Lake City, Utah , USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adam P","family":"Bress","sequence":"additional","affiliation":[{"name":"Intermountain Healthcare Department of Population Health Sciences, Spencer Fox Eccles School of Medicine, University of Utah , Salt Lake City, Utah , USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ransmond O","family":"Berchie","sequence":"additional","affiliation":[{"name":"Intermountain Healthcare Department of Population Health Sciences, Spencer Fox Eccles School of Medicine, University of Utah , Salt Lake City, Utah , USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jennifer S","family":"Herrick","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Spencer Fox Eccles School of Medicine, University of Utah , Salt Lake City, Utah , USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jincheng","family":"Shen","sequence":"additional","affiliation":[{"name":"Intermountain Healthcare Department of Population Health Sciences, Spencer Fox Eccles School of Medicine, University of Utah , Salt Lake City, Utah , USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jian","family":"Ying","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Spencer Fox Eccles School of Medicine, University of Utah , Salt Lake City, Utah , USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tom","family":"Greene","sequence":"additional","affiliation":[{"name":"Intermountain Healthcare Department of Population Health Sciences, Spencer Fox Eccles School of Medicine, University of Utah , Salt Lake City, Utah , USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gabriel S","family":"Tajeu","sequence":"additional","affiliation":[{"name":"Department of Health Services Administration and Policy, Temple University , Philadelphia, Pennsylvania , USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Swati","family":"Sakhuja","sequence":"additional","affiliation":[{"name":"Department of Epidemiology, University of Alabama at Birmingham , Birmingham, Alabama , USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Natalia","family":"Ruiz-Negr\u00f3n","sequence":"additional","affiliation":[{"name":"Department of Pharmacotherapy, University of Utah College of Pharmacy , Salt Lake City, Utah , USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yiyi","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Medicine, Columbia University Irving Medical Center , New York, New York , USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"George","family":"Howard","sequence":"additional","affiliation":[{"name":"Department of Epidemiology, University of Alabama at Birmingham , Birmingham, Alabama , USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emily B","family":"Levitan","sequence":"additional","affiliation":[{"name":"Department of Epidemiology, University of Alabama at Birmingham , Birmingham, Alabama , USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4711-5492","authenticated-orcid":false,"given":"Paul","family":"Muntner","sequence":"additional","affiliation":[{"name":"Department of Epidemiology, University of Alabama at Birmingham , Birmingham, Alabama , USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Monika M","family":"Safford","sequence":"additional","affiliation":[{"name":"Department of Medicine, Weill Cornell Medical College , New York, New York , USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2225-383X","authenticated-orcid":false,"given":"Paul K","family":"Whelton","sequence":"additional","affiliation":[{"name":"Department of Epidemiology, Tulane University School of Public Health and Tropical Medicine , New Orleans, Louisiana , USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"William S","family":"Weintraub","sequence":"additional","affiliation":[{"name":"Department of Medicine, Georgetown University , Washington, District of Columbia , USA"},{"name":"MedStar Health Research Institute , Washington, District of Columbia , USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrew E","family":"Moran","sequence":"additional","affiliation":[{"name":"Department of Medicine, Columbia University Irving Medical Center , New York, New York , USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brandon K","family":"Bellows","sequence":"additional","affiliation":[{"name":"Department of Medicine, Columbia University Irving Medical Center , New York, New York , USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2023,6,28]]},"reference":[{"key":"2023081409270378300_CIT0001","doi-asserted-by":"crossref","first-page":"2103","DOI":"10.1056\/NEJMoa1511939","article-title":"A randomized trial of intensive versus standard blood-pressure control","volume":"373","author":"Wright","year":"2015","journal-title":"N Engl J Med"},{"key":"2023081409270378300_CIT0002","doi-asserted-by":"crossref","first-page":"1921","DOI":"10.1056\/NEJMoa1901281","article-title":"Final report of a trial of intensive versus standard blood-pressure control","volume":"384","author":"SPRINT Research Group","year":"2021","journal-title":"N Engl J Med"},{"key":"2023081409270378300_CIT0003","doi-asserted-by":"crossref","first-page":"2560","DOI":"10.1001\/jama.289.19.2560","article-title":"The seventh report of the Joint National Committee on prevention, detection, evaluation, and treatment of high blood pressure: the JNC7 report","volume":"289","author":"Chobanian","year":"2003","journal-title":"JAMA"},{"key":"2023081409270378300_CIT0004","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1056\/NEJMsa1616035","article-title":"Cost-effectiveness of intensive versus standard blood-pressure control","volume":"377","author":"Bress","year":"2017","journal-title":"N Engl J Med"},{"key":"2023081409270378300_CIT0005","doi-asserted-by":"crossref","first-page":"1617","DOI":"10.1161\/CIRCULATIONAHA.116.025322","article-title":"Potential deaths averted and serious adverse events incurred from adoption of the SPRINT intensive blood pressure regimen in the United States: projections from NHANES","volume":"135","author":"Bress","year":"2017","journal-title":"Circulation"},{"key":"2023081409270378300_CIT0006","doi-asserted-by":"crossref","first-page":"1977","DOI":"10.1016\/j.jacc.2021.02.058","article-title":"Patient selection for intensive blood pressure treatment based on benefit and adverse events","volume":"77","author":"Bress","year":"2021","journal-title":"J Am Coll Cardiol"},{"key":"2023081409270378300_CIT0007","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1177\/1740774514537404","article-title":"The design and rationale of a multicenter clinical trial comparing two strategies for control of systolic blood pressure: the Systolic Blood Pressure Intervention Trial (SPRINT)","volume":"11","author":"Ambrosius","year":"2014","journal-title":"Clin Trials"},{"key":"2023081409270378300_CIT0008","author":"SPRINT Research Group"},{"key":"2023081409270378300_CIT0009","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1159\/000086678","article-title":"The reasons for geographic and racial differences in stroke study: objectives and design","volume":"25","author":"Howard","year":"2005","journal-title":"Neuroepidemiology"},{"key":"2023081409270378300_CIT0010","author":"National Center for Health Statistics"},{"key":"2023081409270378300_CIT0011","first-page":"1","article-title":"National Health and Nutrition Examination Survey: plan and operations, 1999\u20132010","volume":"1","author":"Zipf","year":"2013","journal-title":"Vital Health Stat"},{"key":"2023081409270378300_CIT0012","author":"National Center for Health Statistics"},{"key":"2023081409270378300_CIT0013","author":"National Center for Health Statistics"},{"key":"2023081409270378300_CIT0014","doi-asserted-by":"crossref","first-page":"35","DOI":"10.7326\/M18-3667","article-title":"The Predictive Approaches to Treatment effect Heterogeneity (PATH) statement","volume":"172","author":"Kent","year":"2020","journal-title":"Ann Intern Med"},{"key":"2023081409270378300_CIT0015","doi-asserted-by":"crossref","first-page":"e1002538","DOI":"10.1371\/journal.pmed.1002538","article-title":"Blood pressure-lowering treatment strategies based on cardiovascular risk versus blood pressure: a meta-analysis of individual participant data","volume":"15","author":"Karmali","year":"2018","journal-title":"PLoS Med"},{"key":"2023081409270378300_CIT0016","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.1001\/jama.2015.13480","article-title":"The propensity score","volume":"314","author":"Haukoos","year":"2015","journal-title":"J Am Med Assoc"},{"key":"2023081409270378300_CIT0017","doi-asserted-by":"crossref","DOI":"10.1201\/9780429246593","volume-title":"An Introduction to the Bootstrap","author":"Efron","year":"1994"},{"key":"2023081409270378300_CIT0018","doi-asserted-by":"crossref","first-page":"e190005","DOI":"10.1001\/jamanetworkopen.2019.0005","article-title":"Assessment of risk of harm associated with intensive blood pressure management among patients with hypertension who smoke: a secondary analysis of the Systolic Blood Pressure Intervention Trial","volume":"2","author":"Scarpa","year":"2019","journal-title":"JAMA Netw Open"},{"key":"2023081409270378300_CIT0019","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1038\/s41746-019-0156-3","article-title":"Translating clinical trial results into personalized recommendations by considering multiple outcomes and subjective views","volume":"2","author":"Dagan","year":"2019","journal-title":"NPJ Digit Med"},{"key":"2023081409270378300_CIT0020","doi-asserted-by":"crossref","first-page":"e003624","DOI":"10.1161\/CIRCOUTCOMES.117.003624","article-title":"Personalizing the intensity of blood pressure control: modeling the heterogeneity of risks and benefits from the SPRINT trial: personalizing intensity of blood pressure control","volume":"10","author":"Patel","year":"2017","journal-title":"Circ Cardiovasc Qual Outcomes"},{"key":"2023081409270378300_CIT0021","doi-asserted-by":"crossref","first-page":"e1002410","DOI":"10.1371\/journal.pmed.1002410","article-title":"Benefit and harm of intensive blood pressure treatment: derivation and validation of risk models using data from the SPRINT and ACCORD trials","volume":"14","author":"Basu","year":"2017","journal-title":"PLoS Med"},{"key":"2023081409270378300_CIT0022","first-page":"81","article-title":"Individualizing treatment choices in the systolic blood pressure intervention trial","volume":"36","author":"Ferreira","year":"2017","journal-title":"J Hypertens"},{"key":"2023081409270378300_CIT0023","doi-asserted-by":"crossref","first-page":"e005010","DOI":"10.1161\/CIRCOUTCOMES.118.005010","article-title":"Clinical value of predicting individual treatment effects for intensive blood pressure therapy","volume":"12","author":"Duan","year":"2019","journal-title":"Circ Cardiovasc Qual Outcomes"},{"key":"2023081409270378300_CIT0024","doi-asserted-by":"crossref","first-page":"1767","DOI":"10.1002\/sim.7623","article-title":"Some methods for heterogeneous treatment effect estimation in high dimensions","volume":"37","author":"Powers","year":"2018","journal-title":"Stat Med"},{"key":"2023081409270378300_CIT0025","doi-asserted-by":"crossref","first-page":"1601","DOI":"10.1016\/j.jacc.2018.01.074","article-title":"Impact of cardiovascular risk on the relative benefit and harm of intensive treatment of hypertension","volume":"71","author":"Phillips","year":"2018","journal-title":"J Am Coll Cardiol"},{"key":"2023081409270378300_CIT0026","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1161\/CIRCULATIONAHA.117.027362","article-title":"Incident cardiovascular disease among adults with blood pressure &lt;140\/90 mm Hg","volume":"136","author":"Tajeu","year":"2017","journal-title":"Circulation"},{"key":"2023081409270378300_CIT0027","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1001\/jamacardio.2022.3345","article-title":"Longer-term all-cause and cardiovascular mortality with intensive blood pressure control","volume":"7","author":"Jaeger","year":"2022","journal-title":"JAMA Cardiol"},{"key":"2023081409270378300_CIT0028","first-page":"e426","article-title":"2017 ACC\/AHA\/AAPA\/ABC\/ACPM\/AGS\/APhA\/ASH\/ASPC\/NMA\/PCNA Guideline for the prevention, detection, evaluation, and management of high blood pressure in adults: executive summary: a report of the American College of Cardiology\/American Heart Association Task Force on Clinical Practice Guidelines","volume":"138","author":"Whelton","year":"2018","journal-title":"Circulation"},{"key":"2023081409270378300_CIT0029","doi-asserted-by":"crossref","first-page":"2309","DOI":"10.1161\/CIRCULATIONAHA.113.002290","article-title":"Using benefit-based tailored treatment to improve the use of antihypertensive medications","volume":"128","author":"Sussman","year":"2013","journal-title":"Circulation"},{"key":"2023081409270378300_CIT0030","doi-asserted-by":"crossref","first-page":"2446","DOI":"10.1016\/j.jacc.2017.02.066","article-title":"Using predicted cardiovascular disease risk in conjunction with blood pressure to guide antihypertensive medication treatment","volume":"69","author":"Muntner","year":"2017","journal-title":"J Am Coll Cardiol"},{"key":"2023081409270378300_CIT0031","doi-asserted-by":"crossref","first-page":"e17508","DOI":"10.1371\/journal.pone.0017508","article-title":"The global risk approach should be better applied in French hypertensive patients: a comparison between simulation and observation studies","volume":"6","author":"Marchant","year":"2011","journal-title":"PLoS One"},{"key":"2023081409270378300_CIT0032","doi-asserted-by":"crossref","first-page":"e41842","DOI":"10.1371\/journal.pone.0041842","article-title":"Which interventions offer best value for money in primary prevention of cardiovascular disease","volume":"7","author":"Cobiac","year":"2012","journal-title":"PLoS One"},{"key":"2023081409270378300_CIT0033","doi-asserted-by":"crossref","first-page":"e2","DOI":"10.1161\/HYPERTENSIONAHA.116.08249","article-title":"Global risk assessment to guide blood pressure management in cardiovascular disease prevention","volume":"69","author":"Karmali","year":"2017","journal-title":"Hypertension"},{"key":"2023081409270378300_CIT0034","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1056\/NEJMoa1001286","article-title":"Effects of intensive blood-pressure control in type 2 diabetes mellitus","volume":"362","author":"Cushman","year":"2010","journal-title":"N Engl J Med"},{"key":"2023081409270378300_CIT0035","doi-asserted-by":"crossref","first-page":"1688","DOI":"10.1161\/HYPERTENSIONAHA.120.14653","article-title":"Blood pressure management in stroke","volume":"76","author":"Gorelick","year":"2020","journal-title":"Hypertension"},{"key":"2023081409270378300_CIT0036","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1001\/jamacardio.2017.5365","article-title":"Systolic blood pressure and outcomes in patients with heart failure with preserved ejection fraction","volume":"3","author":"Tsimploulis","year":"2018","journal-title":"JAMA Cardiol"},{"key":"2023081409270378300_CIT0037","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1146\/annurev-statistics-042522-103837","article-title":"A review of generalizability and transportability","volume":"10","author":"Degtiar","year":"2023","journal-title":"Annu Rev Stat Appl"},{"key":"2023081409270378300_CIT0038","doi-asserted-by":"crossref","first-page":"2508","DOI":"10.1111\/jgs.16749","article-title":"Generalizability of blood pressure lowering trials to older patients: cross-sectional analysis","volume":"68","author":"Sheppard","year":"2020","journal-title":"J Am Geriatr Soc"},{"key":"2023081409270378300_CIT0039","doi-asserted-by":"crossref","first-page":"e019707","DOI":"10.1161\/JAHA.120.019707","article-title":"Characteristics of populations excluded from clinical trials supporting intensive blood pressure control guidelines","volume":"10","author":"Anderson","year":"2021","journal-title":"J Am Heart Assoc"},{"key":"2023081409270378300_CIT0040","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1001\/jamainternmed.2020.0051","article-title":"Generalizability of clinical trials supporting the 2017 American College of Cardiology\/American Heart Association Blood Pressure Guideline","volume":"180","author":"Anderson","year":"2020","journal-title":"JAMA Intern Med"},{"key":"2023081409270378300_CIT0041","doi-asserted-by":"crossref","first-page":"430","DOI":"10.7326\/M16-1785","article-title":"Pharmacologic treatment of hypertension in adults aged 60 years or older to higher versus lower blood pressure targets: a clinical practice guideline from the American College of Physicians and the American Academy of Family Physicians","volume":"166","author":"Qaseem","year":"2017","journal-title":"Ann Intern Med"},{"key":"2023081409270378300_CIT0042","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1002\/jgf2.176","article-title":"Overdiagnosis or not? 2017 ACC\/AHA high blood pressure clinical practice guideline: consequences of intellectual conflict of interest","volume":"19","author":"Miyazaki","year":"2018","journal-title":"J Gen Fam Med"},{"key":"2023081409270378300_CIT0043","doi-asserted-by":"crossref","first-page":"692","DOI":"10.7326\/M15-3123","article-title":"Let\u2019s not SPRINT to judgment about new blood pressure goals","volume":"164","author":"Ortiz","year":"2016","journal-title":"Ann Intern Med"},{"key":"2023081409270378300_CIT0044","doi-asserted-by":"crossref","first-page":"2673","DOI":"10.1001\/jama.2016.7050","article-title":"Intensive vs standard blood pressure control and cardiovascular disease outcomes in adults aged \u226575 years","volume":"315","author":"Williamson","year":"2016","journal-title":"JAMA"},{"key":"2023081409270378300_CIT0045","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1111\/jgs.16272","article-title":"Intensive vs standard blood pressure control in adults 80 years or older: a secondary analysis of the Systolic Blood Pressure Intervention Trial","volume":"68","author":"Pajewski","year":"2020","journal-title":"J Am Geriatr Soc"},{"key":"2023081409270378300_CIT0046","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1053\/j.ajkd.2017.08.021","article-title":"Effects of intensive blood pressure treatment on acute kidney injury events in the Systolic Blood Pressure Intervention Trial (SPRINT)","volume":"71","author":"Rocco","year":"2018","journal-title":"Am J Kidney Dis"},{"key":"2023081409270378300_CIT0047","doi-asserted-by":"crossref","first-page":"2071","DOI":"10.1161\/HYPERTENSIONAHA.121.17233","article-title":"Blood pressure intervention and control in SPRINT","volume":"79","author":"Cushman","year":"2022","journal-title":"Hypertension"},{"key":"2023081409270378300_CIT0048","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1161\/HYPERTENSIONAHA.122.20373","article-title":"Antihypertensive medication regimens used in the Systolic Blood Pressure Intervention Trial","volume":"80","author":"Derington","year":"2023","journal-title":"Hypertension"}],"container-title":["American Journal of Hypertension"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ajh\/advance-article-pdf\/doi\/10.1093\/ajh\/hpad047\/50855818\/hpad047.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ajh\/article-pdf\/36\/9\/498\/51043632\/hpad047.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ajh\/article-pdf\/36\/9\/498\/51043632\/hpad047.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,14]],"date-time":"2023-08-14T09:28:03Z","timestamp":1692005283000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ajh\/article\/36\/9\/498\/7209344"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6,28]]},"references-count":48,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2023,6,28]]},"published-print":{"date-parts":[[2023,8,5]]}},"URL":"https:\/\/doi.org\/10.1093\/ajh\/hpad047","relation":{},"ISSN":["0895-7061","1941-7225"],"issn-type":[{"value":"0895-7061","type":"print"},{"value":"1941-7225","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2023,9,1]]},"published":{"date-parts":[[2023,6,28]]}}}